BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17071010)

  • 1. Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS).
    Blum K; Chen TJ; Meshkin B; Downs BW; Gordon CA; Blum S; Mangucci JF; Braverman ER; Arcuri V; Deutsch R; Pons MM
    Med Hypotheses; 2007; 68(4):844-52. PubMed ID: 17071010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reward deficiency syndrome in obesity: a preliminary cross-sectional trial with a Genotrim variant.
    Blum K; Chen TJ; Meshkin B; Downs BW; Gordon CA; Blum S; Mengucci JF; Braverman ER; Arcuri V; Varshavskiy M; Deutsch R; Martinez-Pons M
    Adv Ther; 2006; 23(6):1040-51. PubMed ID: 17276971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reward deficiency syndrome: genetic aspects of behavioral disorders.
    Comings DE; Blum K
    Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
    Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
    Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and glucose, obesity, and reward deficiency syndrome.
    Blum K; Thanos PK; Gold MS
    Front Psychol; 2014; 5():919. PubMed ID: 25278909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LG839: anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome.
    Blum K; Chen AL; Chen TJ; Rhoades P; Prihoda TJ; Downs BW; Waite RL; Williams L; Braverman ER; Braverman D; Arcuri V; Kerner M; Blum SH; Palomo T
    Adv Ther; 2008 Sep; 25(9):894-913. PubMed ID: 18781289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does dopaminergic reward system contribute to explaining comorbidity obesity and ADHD?
    Liu LL; Li BM; Yang J; Wang YW
    Med Hypotheses; 2008; 70(6):1118-20. PubMed ID: 18158220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.
    Blum K; Braverman ER; Holder JM; Lubar JF; Monastra VJ; Miller D; Lubar JO; Chen TJ; Comings DE
    J Psychoactive Drugs; 2000 Nov; 32 Suppl():i-iv, 1-112. PubMed ID: 11280926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?
    Blum K; Gold MS; Llanos-Gomez L; Jalali R; Thanos PK; Bowirrat A; Downs WB; Bagchi D; Braverman ER; Baron D; Roy AK; Badgaiyan RD
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574696
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
    Blum K; Gold MS
    Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
    Blum K; Chen TJ; Chen AL; Madigan M; Downs BW; Waite RL; Braverman ER; Kerner M; Bowirrat A; Giordano J; Henshaw H; Gold MS
    Med Hypotheses; 2010 Mar; 74(3):513-20. PubMed ID: 19914781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
    Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
    Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA based customized nutraceutical "gene therapy" utilizing a genoscore: a hypothesized paradigm shift of a novel approach to the diagnosis, stratification, prognosis and treatment of inflammatory processes in the human.
    Blum K; Meshkin B; Downs BW
    Med Hypotheses; 2006; 66(5):1008-18. PubMed ID: 16403602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms.
    Blum K; Simpatico T; Badgaiyan RD; Demetrovics Z; Fratantonio J; Agan G; Febo M; Gold MS
    J Reward Defic Syndr; 2015; 1(2):75-80. PubMed ID: 27617300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
    Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
    Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.
    Blum K; Bowirrat A; Braverman ER; Baron D; Cadet JL; Kazmi S; Elman I; Thanos PK; Badgaiyan RD; Downs WB; Bagchi D; Llanos-Gomez L; Gold MS
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit-hyperactivity disorder and reward deficiency syndrome.
    Blum K; Chen AL; Braverman ER; Comings DE; Chen TJ; Arcuri V; Blum SH; Downs BW; Waite RL; Notaro A; Lubar J; Williams L; Prihoda TJ; Palomo T; Oscar-Berman M
    Neuropsychiatr Dis Treat; 2008 Oct; 4(5):893-918. PubMed ID: 19183781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
    Blum K; Febo M; Thanos PK; Baron D; Fratantonio J; Gold M
    Mol Neurobiol; 2015 Dec; 52(3):1862-1869. PubMed ID: 25750061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
    Blum K; Dennen CA; Elman I; Bowirrat A; Thanos PK; Badgaiyan RD; Downs BW; Bagchi D; Baron D; Braverman ER; Gupta A; Green R; McLaughlin T; Barh D; Gold MS
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery.
    Blum K; Bailey J; Gonzalez AM; Oscar-Berman M; Liu Y; Giordano J; Braverman E; Gold M
    J Genet Syndr Gene Ther; 2011 Dec; 2012(1):. PubMed ID: 23483116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.